Oncogenic mutations within the β3-αC loop of EGFR/ERBB2/BRAF/MAP2K1 predict response to therapies.
Zhang B, Chen Y, Dai P, Yu H, Ma J, Chen C, Zhang Y, Guan Y, Chen R, Liu T, Wang J, Yang L, Yi X, Xia X, Ma H.
Zhang B, et al. Among authors: yu h.
Mol Genet Genomic Med. 2020 Oct;8(10):e1395. doi: 10.1002/mgg3.1395. Epub 2020 Aug 5.
Mol Genet Genomic Med. 2020.
PMID: 32757330
Free PMC article.